SCANPHARM A/S

CVR 16279099 · Public limited company (A/S) · Active · Low risk

SCANPHARM A/S is a Public limited company (A/S), founded on , based in Birkerød. The company is registered in the industry fremstilling af farmaceutiske præparater. Our model estimates a bankruptcy risk of 0.0% over the next 12 months, which is 0.0 times the average for Danish companies. 20 annual reports have been published, of which 5 more than six months after the end of the financial year. The latest annual report (31 Dec 2025) shows equity of DKK 3.0m and a net result of DKK 963k.

Bankruptcy risk for SCANPHARM A/S

0.0%
probability of bankruptcy within 12 months
Low risk

0.0 × the average (1.41%) · higher risk than 6% of active Danish companies

Lowest riskHighest risk

Increases the risk

Equity vs. share capital1× · bankruptcy rate 12.9%1.5×
Number of CEOs0 · bankruptcy rate 12.7%1.4×
Current ratio50%–100% · bankruptcy rate 11.7%1.3×
RegionHovedstaden · bankruptcy rate 11.6%1.3×
CEO's other companies0 · bankruptcy rate 10.9%1.2×
Share of late annual reports25%–50% · bankruptcy rate 10.6%1.2×
Equity ratio0%–10% · bankruptcy rate 10.2%1.2×

Reduces the risk

Age (years)20+ yrs · bankruptcy rate 2.0%0.23×
Published annual reports10+ · bankruptcy rate 3.0%0.35×
Time at current address5+ yrs · bankruptcy rate 3.1%0.35×
Number of auditors (historical)3+ · bankruptcy rate 3.7%0.42×
Company typeA/S · bankruptcy rate 4.4%0.50×
Gross profit growth10%–30% · bankruptcy rate 4.5%0.51×
Auditor registered in CVRYes · bankruptcy rate 4.8%0.55×
Audit opted outNo · bankruptcy rate 4.8%0.55×

The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.

Company details

CVR number
16279099
Status
Active
Company type
Public limited company (A/S)
Founded
(34 years)
Address
Topstykket 12
3460 Birkerød
Municipality
Rudersdal
Industry
Fremstilling af farmaceutiske præparater (212000)
Bankruptcies in the industry: Fremstilling af farmaceutiske præparater
Share capital
DKK 3.0m
Employees
51 (2018)
Auditor
Bent Lind Kofoed
Audit opted out
No

Warning signs

Annual reports filed late9 of 31
Missing annual reportNo
Negative equityNo
Equity ratio7.8%
Current ratio74%
Moves (last 2 years)0
CEO changes in total4
CEO's previous bankruptcies0
Other companies at the address2
Going-concern uncertaintyNo

Financials and key figures

Financial year202520242023
Gross profitDKK 29.7mDKK 26.9mDKK 22.5m
Net profitDKK 963kDKK 583kDKK -4.4m
EquityDKK 3.0mDKK 2.1mDKK 1.5m
Total assetsDKK 39.2mDKK 35.1mDKK 31.6m
Short-term debtDKK 33.0mDKK 29.8m–
Avg. employees042–

Latest annual report: Reporting class B · auditor's statement: Den uafhængige revisors erklæring · KRESTON CMStatsautoriseret Revisionsinteressentskab.

Filed annual reports

Reporting periodPublishedDays after period end
1 Jan 2025 – 31 Dec 2025166
1 Jan 2024 – 31 Dec 2024140
1 Jan 2023 – 31 Dec 2023184 Late
1 Jan 2022 – 31 Dec 2022184 Late
1 Jan 2021 – 31 Dec 2021186 Late
1 Jan 2020 – 31 Dec 2020190 Late
1 Jan 2019 – 31 Dec 2019246 Late
1 Jan 2018 – 31 Dec 2018176
1 Jan 2017 – 31 Dec 2017155
1 Jan 2016 – 31 Dec 2016153
1 Jan 2015 – 31 Dec 2015151
1 Jan 2014 – 31 Dec 2014152
1 Jan 2013 – 31 Dec 2013152
1 Jan 2012 – 31 Dec 2012150
1 Jan 2011 – 31 Dec 2011120
1 Jan 2010 – 31 Dec 2010153
1 Jan 2009 – 31 Dec 2009153
1 Jan 2008 – 31 Dec 2008162
1 Jan 2007 – 31 Dec 2007136
1 Jan 2006 – 31 Dec 2006161

The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.

Management, owners and auditor

RoleNameFromTo
CEOOle Bjørn Jensen
CEOPer Emil Hasselbalch Stakemann
CEORolf Eckersberg
BoardHanne Bjørn JensenCurrent
BoardJanus Doré PaghCurrent
BoardAndreas Bjørn JensenCurrent
BoardOle Bjørn Jensen
BoardHans Christian Galst
BoardKim Aage Egegaard
BoardUlf Svejgaard Poulsen
BoardPer Emil Hasselbalch Stakemann
BoardJens Terkel Lund-Nielsen
BoardHolger Carsten Hansen
Owner (10%)Peluli Holding ApSCurrent
Owner (90%)CHLOPETHAN A/SCurrent
Owner (100%)CHLOPETHAN A/S
Owner (10%)E CONSULT ApS
Owner (67%)CHLOPETHAN A/S
AuditorBent Lind KofoedCurrent
AuditorErik Tronborg Andersen
AuditorRL KØBENHAVN A/S
FounderVX 10.312 ApSCurrent
FounderMEDIMEX ApSCurrent
FounderApS KBIL 9 NR. 1008Current

The CEOs' other companies

Ole Bjørn Jensen – 9 other companies

Per Emil Hasselbalch Stakemann – 45 other companies, of which 45 bankrupt

Rolf Eckersberg – 21 other companies, of which 1 bankrupt

Address history (1 moves)

Topstykket 12, 3460 Birkerød
Topstykket 12, 3460 Birkerød

Former names

SCANPHARM A/S – now
SCANPHARM A/S AF 1992 –
A/S SCANPHARM AF 1992 –
A/S PSE NR. 4681 –

Employees per year

Number of employees at SCANPHARM A/S per year26512011: 5020112012: 4820122013: 4420132014: 4820142015: 4420152016: 4220162017: 4520172018: 512018

Other companies at the same address

Similar companies in Rudersdal

Questions and answers about SCANPHARM A/S

Has SCANPHARM A/S gone bankrupt?

No, SCANPHARM A/S is not registered as bankrupt in the CVR register. Its status is: active.

What is the bankruptcy risk of SCANPHARM A/S?

Our model estimates a bankruptcy risk of 0.0% over the next 12 months (low risk), which is 0.0 times the average for Danish companies.

Who is the auditor of SCANPHARM A/S?

SCANPHARM A/S most recently used Bent Lind Kofoed.

When was SCANPHARM A/S founded?

SCANPHARM A/S was founded on 1 July 1992.

What is the equity of SCANPHARM A/S?

Equity was DKK 3.0m according to the annual report for the period ending 31 December 2025.

Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.